Eve & Co Incorporated (TSXV:EVE), a Canadian cannabis stock, moved higher after announcing Health Canada approval for expansion of its licensed grow and operation areas
More growing space was great news for investors in a Canadian cannabis stock Monday. Here’s some small stocks making big moves on Monday, December 10, 2018 (as of 4 pm EST):
Eve & Co Incorporated (TSXV:EVE), a Canadian cannabis stock, jumped 15% to $0.275 on Monday after announcing that Health Canada has authorized Natural MedCo Ltd., its wholly-owned subsidiary, to use its previously-constructed 100,000 sq. ft. second flowering room as a grow area, and a packaging room as an operations area. With the addition of these approved areas, Eve & Co now has 220,000 sq. ft. of licensed grow and operation areas, with harvesting at its second flowering room expected by late March 2019.
As well, shares of Lydian International Limited (TSX:LYD) gained 23% to $0.16 as the gold junior said that the Administrative Court of the Republic of Armenia has accepted the Company’s lawsuit appealing a directive issued by Mr. Artur Grigoryan, the head of the Republic of Armenia’s Environmental and Mining Inspection Body, to refrain from any mining-related activities at the Amulsar project.
Perisson Petroleum Corporation (TSXV:POG), meanwhile, reported that it has signed an investment agreement, in which Lan-cheng Limited, General Partner to Lan-cheng Westcity LP, has agreed to invest up to US$50 million into Perisson by way of a private placement at an approximate price of US$0.95413 per unit. Perisson Petroleum stock moved up 18% to $0.33 following the announcement.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Eve & Co Incorporated (TSXV:EVE), a Canadian cannabis stock, jumped 15% to $0.275 on Monday after announcing that Health Canada has authorized Natural MedCo Ltd., its wholly-owned subsidiary, to use its previously-constructed 100,000 sq. ft. second flowering room as a grow area, and a packaging room as an operations area. With the addition of these approved areas, Eve & Co now has 220,000 sq. ft. of licensed grow and operation areas, with harvesting at its second flowering room expected by late March 2019.
